MEDINDIA
English
हिन्दी
Español
français
中文
Email
Acebutolol
Eprosartan may increase the hypotensive activities of Acebutolol.
Aceclofenac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Aceclofenac.
Acemetacin
The therapeutic efficacy of Eprosartan can be decreased when used in combination with Acemetacin.
Acetyl salicylate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Acetylsalicylic acid.
Adapalene
The risk or severity of adverse effects can be increased when Eprosartan is combined with Adapalene.
Aldesleukin
The risk or severity of adverse effects can be increased when Aldesleukin is combined with Eprosartan.
Alfuzosin
Alfuzosin may increase the hypotensive activities of Eprosartan.
Aliskiren
Aliskiren may increase the hyperkalemic activities of Eprosartan.
Alminoprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Alminoprofen.
Alprenolol
Alprenolol may increase the hypotensive activities of Eprosartan.
Ambrisentan
Eprosartan may increase the hypotensive activities of Ambrisentan.
Amifostine
Eprosartan may increase the hypotensive activities of Amifostine.
Amifostine Anhydrous
Eprosartan may increase the hypotensive activities of Amifostine.
Amiloride
Eprosartan may increase the hyperkalemic activities of Amiloride.
Amiodarone
The risk or severity of adverse effects can be increased when Amiodarone is combined with Eprosartan.
Amlodipine
Amlodipine may increase the hypotensive activities of Eprosartan.
Amobarbital
Amobarbital may increase the hypotensive activities of Eprosartan.
Amphetamine
Amphetamine may increase the hypotensive activities of Eprosartan.
Amphotericin B
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eprosartan.
amphotericin B liposomal
The risk or severity of adverse effects can be increased when Amphotericin B is combined with Eprosartan.
Amyl Nitrite
The risk or severity of adverse effects can be increased when Eprosartan is combined with Amyl Nitrite.
Antipyrine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Antipyrine.
Apazone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Azapropazone.
Apomorphine
The risk or severity of adverse effects can be increased when Apomorphine is combined with Eprosartan.
Apraclonidine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Apraclonidine.
Apremilast
The risk or severity of adverse effects can be increased when Eprosartan is combined with Apremilast.
Ardeparin
Ardeparin may increase the hyperkalemic activities of Eprosartan.
Aripiprazole
Aripiprazole may increase the hypotensive activities of Eprosartan.
Arsenic Trioxide
The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Eprosartan.
Aspirin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Acetylsalicylic acid.
Atenolol
Atenolol may increase the hypotensive activities of Eprosartan.
Avanafil
Avanafil may increase the antihypertensive activities of Eprosartan.
Azelastine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Azelastine.
Azilsartan
The risk or severity of adverse effects can be increased when Eprosartan is combined with Azilsartan medoxomil.
Azilsartan kamedoxomil
The risk or severity of adverse effects can be increased when Eprosartan is combined with Azilsartan medoxomil.
Azilsartan Medoxomil
The risk or severity of adverse effects can be increased when Eprosartan is combined with Azilsartan medoxomil.
Balsalazide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Balsalazide.
Barbexaclone
Barbexaclone may increase the hypotensive activities of Eprosartan.
Barbital
Barbital may increase the hypotensive activities of Eprosartan.
Bemiparin
Bemiparin may increase the hyperkalemic activities of Eprosartan.
Benazepril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Benazepril.
Bendroflumethiazide
Bendroflumethiazide may increase the hypotensive activities of Eprosartan.
Benzydamine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Benzydamine.
Bepridil
Eprosartan may increase the hypotensive activities of Bepridil.
Betaxolol
Betaxolol may increase the hypotensive activities of Eprosartan.
Bethanidine
Bethanidine may increase the hypotensive activities of Eprosartan.
Bimatoprost
Eprosartan may increase the hypotensive activities of Bimatoprost.
Bisoprolol
Bisoprolol may increase the hypotensive activities of Eprosartan.
Bortezomib
The risk or severity of adverse effects can be increased when Bortezomib is combined with Eprosartan.
Bosentan
Bosentan may increase the hypotensive activities of Eprosartan.
Bosentan Anhydrous
Bosentan may increase the hypotensive activities of Eprosartan.
Bretylium
Eprosartan may increase the hypotensive activities of Bretylium.
Brimonidine
Brimonidine may increase the antihypertensive activities of Eprosartan.
Bromfenac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Bromfenac.
Bromocriptine
The risk or severity of adverse effects can be increased when Bromocriptine is combined with Eprosartan.
Bufexamac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Bufexamac.
Bumetanide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Bumetanide.
Bupivacaine
The risk or severity of adverse effects can be increased when Bupivacaine is combined with Eprosartan.
Bupranolol
Eprosartan may increase the hypotensive activities of Bupranolol.
Cafedrine
Eprosartan may increase the hypotensive activities of Cafedrine.
Canagliflozin
Canagliflozin may increase the hyperkalemic activities of Eprosartan.
Canagliflozin Anhydrous
Canagliflozin may increase the hyperkalemic activities of Eprosartan.
Candesartan
Eprosartan may increase the hypotensive activities of Candesartan.
Candesartan Cilexetil
Candesartan cilexetil may increase the hypotensive activities of Eprosartan.
Captopril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Captopril.
Carprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Carprofen.
Carteolol
Carteolol may increase the hypotensive activities of Eprosartan.
Carvedilol
Eprosartan may increase the hypotensive activities of Carvedilol.
Celecoxib
The risk or severity of adverse effects can be increased when Eprosartan is combined with Celecoxib.
Celiprolol
Eprosartan may increase the hypotensive activities of Celiprolol.
Certoparin
Certoparin may increase the hyperkalemic activities of Eprosartan.
Chloroquine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Chloroquine.
Chlorothiazide
Eprosartan may increase the hypotensive activities of Chlorothiazide.
Chlorpromazine
The risk or severity of adverse effects can be increased when Chlorpromazine is combined with Eprosartan.
Chlorthalidone
Chlorthalidone may increase the hypotensive activities of Eprosartan.
Choline Magnesium Trisalicyclate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Choline magnesium trisalicylate.
Cicletanine
Eprosartan may increase the hypotensive activities of Cicletanine.
Cilazapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Cilazapril.
Ciprofloxacin
Eprosartan may increase the arrhythmogenic activities of Ciprofloxacin.
Clevidipine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Clevidipine.
Clevidipine butyrate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Clevidipine.
Clofarabine
The risk or severity of adverse effects can be increased when Clofarabine is combined with Eprosartan.
Clomipramine
The risk or severity of adverse effects can be increased when Clomipramine is combined with Eprosartan.
Clonidine
Clonidine may increase the hypotensive activities of Eprosartan.
Clonixin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Clonixin.
Clozapine
The risk or severity of adverse effects can be increased when Clozapine is combined with Eprosartan.
Conivaptan
The risk or severity of adverse effects can be increased when Conivaptan is combined with Eprosartan.
Cryptenamine
Cryptenamine may increase the hypotensive activities of Eprosartan.
Curcumin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Curcumin.
Cyclopenthiazide
Eprosartan may increase the hypotensive activities of Cyclopenthiazide.
Cyclosporine
Eprosartan may increase the hyperkalemic activities of Cyclosporine.
Cyclothiazide
Cyclothiazide may increase the hypotensive activities of Eprosartan.
Dalteparin
Dalteparin may increase the hyperkalemic activities of Eprosartan.
Dapagliflozin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Dapagliflozin.
Debrisoquin
Debrisoquin may increase the hypotensive activities of Eprosartan.
Deserpidine
Eprosartan may increase the hypotensive activities of Deserpidine.
Desflurane
The risk or severity of adverse effects can be increased when Desflurane is combined with Eprosartan.
Dexmedetomidine
The risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Eprosartan.
Diazoxide
Diazoxide may increase the hypotensive activities of Eprosartan.
Dichlorphenamide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Diclofenamide.
Diclofenac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Diclofenac.
Diflunisal
The risk or severity of adverse effects can be increased when Eprosartan is combined with Diflunisal.
Dihydralazine
Dihydralazine may increase the hypotensive activities of Eprosartan.
Diltiazem
Diltiazem may increase the hypotensive activities of Eprosartan.
Dinutuximab
The risk or severity of adverse effects can be increased when Eprosartan is combined with Dinutuximab.
Dipyridamole
The risk or severity of adverse effects can be increased when Eprosartan is combined with Dipyridamole.
Dipyrone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Metamizole.
Dorzolamide
Dorzolamide may increase the hypotensive activities of Eprosartan.
Doxazosin
Doxazosin may increase the hypotensive activities of Eprosartan.
Drospirenone
Eprosartan may increase the hyperkalemic activities of Drospirenone.
Droxicam
The risk or severity of adverse effects can be increased when Eprosartan is combined with Droxicam.
Duloxetine
Eprosartan may increase the orthostatic hypotensive activities of Duloxetine.
Empagliflozin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Empagliflozin.
Enalapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Enalapril.
Enalaprilat
The risk or severity of adverse effects can be increased when Eprosartan is combined with Enalaprilat.
Enalaprilat Anhydrous
The risk or severity of adverse effects can be increased when Eprosartan is combined with Enalaprilat.
Enoxaparin
Enoxaparin may increase the hyperkalemic activities of Eprosartan.
Enoxaparin sodium
Enoxaparin may increase the hyperkalemic activities of Eprosartan.
Eplerenone
Eplerenone may increase the hyperkalemic activities of Eprosartan.
Epoprostenol
Eprosartan may increase the hypotensive activities of Epoprostenol.
Esmolol
The risk or severity of adverse effects can be increased when Esmolol is combined with Eprosartan.
Etanercept
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etanercept.
Ethacrynate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etacrynic acid.
Ethacrynic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etacrynic acid.
Etodolac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etodolac.
Etofenamate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etofenamate.
Etoricoxib
The risk or severity of adverse effects can be increased when Eprosartan is combined with Etoricoxib.
Evening primrose oil
The risk or severity of adverse effects can be increased when Eprosartan is combined with Evening primrose oil.
Felbinac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Felbinac.
Felodipine
Eprosartan may increase the hypotensive activities of Felodipine.
Fenbufen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Fenbufen.
Fenoldopam
Fenoldopam may increase the hypotensive activities of Eprosartan.
Fenoprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Fenoprofen.
Ferulic Acid
Eprosartan may increase the hypotensive activities of Ferulic acid.
Floctafenine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Floctafenine.
Flurbiprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Flurbiprofen.
Fosinopril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Fosinopril.
Fostamatinib
Fostamatinib may increase the antihypertensive activities of Eprosartan.
Furazolidone
Furazolidone may increase the hypotensive activities of Eprosartan.
Furosemide
The risk or severity of adverse effects can be increased when Furosemide is combined with Eprosartan.
Guanabenz
Guanabenz may increase the hypotensive activities of Eprosartan.
Guanadrel
Guanadrel may increase the hypotensive activities of Eprosartan.
Guanethidine
Eprosartan may increase the hypotensive activities of Guanethidine.
Guanfacine
Guanfacine may increase the hypotensive activities of Eprosartan.
Halothane
The risk or severity of adverse effects can be increased when Halothane is combined with Eprosartan.
Heparin
Heparin may increase the hyperkalemic activities of Eprosartan.
Hexobarbital
Hexobarbital may increase the hypotensive activities of Eprosartan.
Hydralazine
Hydralazine may increase the hypotensive activities of Eprosartan.
Hydrochlorothiazide
Eprosartan may increase the hypotensive activities of Hydrochlorothiazide.
Hydroflumethiazide
Hydroflumethiazide may increase the hypotensive activities of Eprosartan.
Ibuprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ibuprofen.
Icatibant
The risk or severity of adverse effects can be increased when Eprosartan is combined with Icatibant.
Iloprost
The risk or severity of adverse effects can be increased when Iloprost is combined with Eprosartan.
Imidapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Imidapril.
Imipramine
The risk or severity of adverse effects can be increased when Imipramine is combined with Eprosartan.
Indapamide
Indapamide may increase the hypotensive activities of Eprosartan.
Indobufen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Indobufen.
Indomethacin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Indomethacin.
Indoramin
Indoramin may increase the hypotensive activities of Eprosartan.
Iproniazid
Iproniazid may increase the hypotensive activities of Eprosartan.
Irbesartan
Eprosartan may increase the hypotensive activities of Irbesartan.
Isocarboxazid
Isocarboxazid may increase the hypotensive activities of Eprosartan.
Isoflurane
The risk or severity of adverse effects can be increased when Isoflurane is combined with Eprosartan.
Isosorbide Dinitrate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Isosorbide Dinitrate.
Isosorbide Mononitrate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Isosorbide Mononitrate.
Isoxsuprine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Isoxsuprine.
Isradipine
Isradipine may increase the hypotensive activities of Eprosartan.
Kebuzone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Kebuzone.
Ketanserin
Ketanserin may increase the hypotensive activities of Eprosartan.
Ketoprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ketoprofen.
Ketorolac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ketorolac.
Labetalol
Labetalol may increase the hypotensive activities of Eprosartan.
Lacidipine
Eprosartan may increase the hypotensive activities of Lacidipine.
Latanoprost
Latanoprost may increase the hypotensive activities of Eprosartan.
Leflunomide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Leflunomide.
Lercanidipine
Lercanidipine may increase the hypotensive activities of Eprosartan.
Levobunolol
The risk or severity of adverse effects can be increased when Eprosartan is combined with Levobunolol.
Levobupivacaine
The risk or severity of adverse effects can be increased when Levobupivacaine is combined with Eprosartan.
Levodopa
Eprosartan may increase the orthostatic hypotensive activities of Levodopa.
Levosimendan
The risk or severity of adverse effects can be increased when Levosimendan is combined with Eprosartan.
Limonene, (+)-
The risk or severity of adverse effects can be increased when Eprosartan is combined with (4R)-limonene.
Lisinopril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Lisinopril.
Lisinopril Anhydrous
The risk or severity of adverse effects can be increased when Eprosartan is combined with Lisinopril.
Lithium
The serum concentration of Lithium can be increased when it is combined with Eprosartan.
Lithium Cation
The serum concentration of Lithium can be increased when it is combined with Eprosartan.
Lofexidine
Eprosartan may increase the hypotensive activities of Lofexidine.
Lornoxicam
The risk or severity of adverse effects can be increased when Eprosartan is combined with Lornoxicam.
Losartan
Losartan may increase the hypotensive activities of Eprosartan.
Loxoprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Loxoprofen.
Macitentan
Eprosartan may increase the hypotensive activities of Macitentan.
Magnesium Salicylate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Magnesium salicylate.
Manidipine
Eprosartan may increase the hypotensive activities of Manidipine.
Mannitol
The risk or severity of adverse effects can be increased when Mannitol is combined with Eprosartan.
Masoprocol
The risk or severity of adverse effects can be increased when Eprosartan is combined with Masoprocol.
Mecamylamine
Mecamylamine may increase the hypotensive activities of Eprosartan.
Meclofenamate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Meclofenamic acid.
Meclofenamic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Meclofenamic acid.
Mefenamic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Mefenamic acid.
Meloxicam
The risk or severity of adverse effects can be increased when Eprosartan is combined with Meloxicam.
Mephobarbital
Methylphenobarbital may increase the hypotensive activities of Eprosartan.
Mepirodipine
Eprosartan may increase the antihypertensive activities of Barnidipine.
Mesalamine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Mesalazine.
Methazolamide
The risk or severity of adverse effects can be increased when Methazolamide is combined with Eprosartan.
Methohexital
Methohexital may increase the hypotensive activities of Eprosartan.
Methyclothiazide
The risk or severity of adverse effects can be increased when Methyclothiazide is combined with Eprosartan.
Methyldopa
Eprosartan may increase the hypotensive activities of Methyldopa.
METHYLDOPA ANHYDROUS
Eprosartan may increase the hypotensive activities of Methyldopa.
Methylene blue
Methylene blue may increase the hypotensive activities of Eprosartan.
Methylphenidate
Methylphenidate may decrease the antihypertensive activities of Eprosartan.
Metipranolol
Eprosartan may increase the hypotensive activities of Metipranolol.
Metolazone
Metolazone may increase the hypotensive activities of Eprosartan.
Metoprolol
Metoprolol may increase the hypotensive activities of Eprosartan.
Metyrosine
Eprosartan may increase the hypotensive activities of Metyrosine.
Mibefradil
Eprosartan may increase the hypotensive activities of Mibefradil.
Minaprine
Minaprine may increase the hypotensive activities of Eprosartan.
Minoxidil
Minoxidil may increase the hypotensive activities of Eprosartan.
Moclobemide
Moclobemide may increase the hypotensive activities of Eprosartan.
Moexipril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Moexipril.
Molsidomine
Molsidomine may increase the hypotensive activities of Eprosartan.
Morphine
The risk or severity of adverse effects can be increased when Morphine is combined with Eprosartan.
Moxonidine
Moxonidine may increase the hypotensive activities of Eprosartan.
MYCOPHENOLATE
The risk or severity of adverse effects can be increased when Eprosartan is combined with Mycophenolic acid.
Mycophenolate Mofetil
The risk or severity of adverse effects can be increased when Eprosartan is combined with Mycophenolate mofetil.
Mycophenolic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Mycophenolic acid.
Nabilone
The risk or severity of adverse effects can be increased when Nabilone is combined with Eprosartan.
Nabumetone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Nabumetone.
Nadolol
Eprosartan may increase the hypotensive activities of Nadolol.
Nadroparin
Nadroparin may increase the hyperkalemic activities of Eprosartan.
Naftifine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Naftifine.
Naproxen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Naproxen.
Nebivolol
Eprosartan may increase the hypotensive activities of Nebivolol.
Nepafenac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Nepafenac.
Nesiritide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Nesiritide.
Nialamide
Nialamide may increase the hypotensive activities of Eprosartan.
Nicardipine
Nicardipine may increase the hypotensive activities of Eprosartan.
Nicorandil
Nicorandil may increase the hyperkalemic activities of Eprosartan.
Nifedipine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Nifedipine.
Niflumic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Niflumic Acid.
Nilvadipine
Eprosartan may increase the hypotensive activities of Nilvadipine.
Nimesulide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Nimesulide.
Nimodipine
Nimodipine may increase the hypotensive activities of Eprosartan.
Nisoldipine
Nisoldipine may increase the hypotensive activities of Eprosartan.
Nitrendipine
Eprosartan may increase the hypotensive activities of Nitrendipine.
Nitric Oxide
The risk or severity of adverse effects can be increased when Nitric Oxide is combined with Eprosartan.
Nitroglycerin
The risk or severity of adverse effects can be increased when Nitroglycerin is combined with Eprosartan.
Nitroprusside
Nitroprusside may increase the hypotensive activities of Eprosartan.
Obinutuzumab
Eprosartan may increase the hypotensive activities of Obinutuzumab.
Oenothera biennis seed extract
The risk or severity of adverse effects can be increased when Eprosartan is combined with Evening primrose oil.
Olmesartan
Olmesartan may increase the hypotensive activities of Eprosartan.
Olopatadine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Olopatadine.
Olsalazine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Olsalazine.
Oxaprozin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Oxaprozin.
Oxprenolol
Eprosartan may increase the hypotensive activities of Oxprenolol.
Oxyphenbutazone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Oxyphenbutazone.
Paclitaxel
The risk or severity of adverse effects can be increased when Paclitaxel is combined with Eprosartan.
Palmidrol
The risk or severity of adverse effects can be increased when Eprosartan is combined with Palmidrol.
Papaverine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Papaverine.
Parecoxib
The risk or severity of adverse effects can be increased when Eprosartan is combined with Parecoxib.
Paregoric
The risk or severity of adverse effects can be increased when Morphine is combined with Eprosartan.
Pargyline
Pargyline may increase the hypotensive activities of Eprosartan.
Parnaparin
Parnaparin may increase the hyperkalemic activities of Eprosartan.
Parthenolide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Parthenolide.
Penbutolol
Eprosartan may increase the hypotensive activities of Penbutolol.
Pentobarbital
Pentobarbital may increase the hypotensive activities of Eprosartan.
Pentoxifylline
Pentoxifylline may increase the hypotensive activities of Eprosartan.
Perindopril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Perindopril.
Phenelzine
Phenelzine may increase the hypotensive activities of Eprosartan.
Phenobarbital
Phenobarbital may increase the hypotensive activities of Eprosartan.
Phenoxybenzamine
Eprosartan may increase the hypotensive activities of Phenoxybenzamine.
Phentolamine
Phentolamine may increase the hypotensive activities of Eprosartan.
Phentolamine Mesylate
Phentolamine may increase the hypotensive activities of Eprosartan.
Phenylbutazone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Phenylbutazone.
Pimecrolimus
The risk or severity of adverse effects can be increased when Eprosartan is combined with Pimecrolimus.
Pinacidil
Pinacidil may increase the hypotensive activities of Eprosartan.
Pindolol
Eprosartan may increase the hypotensive activities of Pindolol.
Pipamperone
The risk or severity of adverse effects can be increased when Pipamperone is combined with Eprosartan.
Pirfenidone
The risk or severity of adverse effects can be increased when Eprosartan is combined with Pirfenidone.
Piroxicam
The risk or severity of adverse effects can be increased when Eprosartan is combined with Piroxicam.
Piroxicam-Beta-Cyclodextrin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Piroxicam.
Polythiazide
Eprosartan may increase the hypotensive activities of Polythiazide.
Pramipexole
The risk or severity of adverse effects can be increased when Pramipexole is combined with Eprosartan.
Prazosin
Prazosin may increase the hypotensive activities of Eprosartan.
Primidone
Primidone may increase the hypotensive activities of Eprosartan.
Procaine
Procaine may increase the hypotensive activities of Eprosartan.
Procarbazine
Procarbazine may increase the hypotensive activities of Eprosartan.
Propofol
The risk or severity of adverse effects can be increased when Propofol is combined with Eprosartan.
Propranolol
Propranolol may increase the hypotensive activities of Eprosartan.
Quetiapine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Quetiapine.
Quetiapine fumarate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Quetiapine.
Quinapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Quinapril.
Quinine
Quinine may increase the hypotensive activities of Eprosartan.
Ramipril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Ramipril.
Rasagiline
Rasagiline may increase the hypotensive activities of Eprosartan.
Remifentanil
The risk or severity of adverse effects can be increased when Remifentanil is combined with Eprosartan.
Rescinnamine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Rescinnamine.
Reserpine
Reserpine may increase the hypotensive activities of Eprosartan.
Resveratrol
The risk or severity of adverse effects can be increased when Eprosartan is combined with Resveratrol.
Reviparin
Reviparin may increase the hyperkalemic activities of Eprosartan.
Reviparin sodium
Reviparin may increase the hyperkalemic activities of Eprosartan.
Rilmenidine
Rilmenidine may increase the hypotensive activities of Eprosartan.
Riociguat
Eprosartan may increase the hypotensive activities of Riociguat.
Risperidone
Eprosartan may increase the hypotensive activities of Risperidone.
Rituximab
Eprosartan may increase the hypotensive activities of Rituximab.
Rofecoxib
The risk or severity of adverse effects can be increased when Eprosartan is combined with Rofecoxib.
Ropinirole
The risk or severity of adverse effects can be increased when Ropinirole is combined with Eprosartan.
Ropivacaine
The risk or severity of adverse effects can be increased when Ropivacaine is combined with Eprosartan.
Rotigotine
The risk or severity of adverse effects can be increased when Rotigotine is combined with Eprosartan.
Sacubitril
The risk or severity of adverse effects can be increased when Sacubitril is combined with Eprosartan.
Salicylamide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Salicylamide.
Salicylic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Salicylic acid.
Salsalate
The risk or severity of adverse effects can be increased when Eprosartan is combined with Salsalate.
Secobarbital
Secobarbital may increase the hypotensive activities of Eprosartan.
Selegiline
Selegiline may increase the hypotensive activities of Eprosartan.
Selexipag
Eprosartan may increase the hypotensive activities of Selexipag.
Serratiopeptidase
The risk or severity of adverse effects can be increased when Eprosartan is combined with Serrapeptase.
Sevoflurane
The risk or severity of adverse effects can be increased when Sevoflurane is combined with Eprosartan.
Sildenafil
Sildenafil may increase the antihypertensive activities of Eprosartan.
Sodium Phosphate
Eprosartan may increase the nephrotoxic activities of Sodium phosphate.
Sodium Phosphate, Monobasic
Eprosartan may increase the nephrotoxic activities of Sodium phosphate.
SODIUM PHOSPHATE, MONOBASIC, ANHYDROUS
Eprosartan may increase the nephrotoxic activities of Sodium phosphate.
Sotalol
The risk or severity of adverse effects can be increased when Sotalol is combined with Eprosartan.
Spirapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Spirapril.
Spironolactone
The risk or severity of adverse effects can be increased when Spironolactone is combined with Eprosartan.
Streptokinase
The risk or severity of adverse effects can be increased when Streptokinase is combined with Eprosartan.
Sufentanil
The risk or severity of adverse effects can be increased when Sufentanil is combined with Eprosartan.
Sulfasalazine
The risk or severity of adverse effects can be increased when Eprosartan is combined with Sulfasalazine.
Sulindac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Sulindac.
Suprofen
The risk or severity of adverse effects can be increased when Eprosartan is combined with Suprofen.
Tadalafil
Tadalafil may increase the antihypertensive activities of Eprosartan.
Talinolol
Eprosartan may increase the hypotensive activities of Talinolol.
Tamsulosin
The risk or severity of adverse effects can be increased when Tamsulosin is combined with Eprosartan.
Telmisartan
Eprosartan may increase the hypotensive activities of Telmisartan.
Tenoxicam
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tenoxicam.
Terazosin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Terazosin.
Teriflunomide
The risk or severity of adverse effects can be increased when Eprosartan is combined with Teriflunomide.
Terlipressin
Eprosartan may increase the hypotensive activities of Terlipressin.
Thalidomide
The risk or severity of adverse effects can be increased when Thalidomide is combined with Eprosartan.
Theodrenaline
Eprosartan may increase the hypotensive activities of Theodrenaline.
Theophylline
Theophylline may increase the antihypertensive activities of Eprosartan.
Theophylline anhydrous
Theophylline may increase the antihypertensive activities of Eprosartan.
Thiamylal
Thiamylal may increase the hypotensive activities of Eprosartan.
Thiopental
Thiopental may increase the hypotensive activities of Eprosartan.
Thiopental Sodium
Thiopental may increase the hypotensive activities of Eprosartan.
Thioridazine
The risk or severity of adverse effects can be increased when Thioridazine is combined with Eprosartan.
Tiaprofenic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tiaprofenic acid.
Tibolone
Eprosartan may increase the hypotensive activities of Tibolone.
Timolol
Timolol may increase the hypotensive activities of Eprosartan.
Timolol Anhydrous
Timolol may increase the hypotensive activities of Eprosartan.
Tinzaparin
Tinzaparin may increase the hyperkalemic activities of Eprosartan.
Tinzaparin sodium
Tinzaparin may increase the hyperkalemic activities of Eprosartan.
Tizanidine
The risk or severity of adverse effects can be increased when Tizanidine is combined with Eprosartan.
Tolazoline
Tolazoline may increase the hypotensive activities of Eprosartan.
Tolcapone
The risk or severity of adverse effects can be increased when Tolcapone is combined with Eprosartan.
Tolfenamic Acid
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tolfenamic Acid.
Tolmetin
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tolmetin.
Toloxatone
Toloxatone may increase the hypotensive activities of Eprosartan.
Tolvaptan
Tolvaptan may increase the hyperkalemic activities of Eprosartan.
Torsemide
Torasemide may increase the hypotensive activities of Eprosartan.
Trandolapril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Trandolapril.
Tranilast
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tranilast.
Tranylcypromine
Tranylcypromine may increase the hypotensive activities of Eprosartan.
Travoprost
Travoprost may increase the hypotensive activities of Eprosartan.
Treprostinil
Treprostinil may increase the hypotensive activities of Eprosartan.
Tretinoin
The risk or severity of adverse effects can be increased when Tretinoin is combined with Eprosartan.
Triamterene
Eprosartan may increase the hyperkalemic activities of Triamterene.
Tribenoside
The risk or severity of adverse effects can be increased when Eprosartan is combined with Tribenoside.
Trichlormethiazide
Eprosartan may increase the hypotensive activities of Trichlormethiazide.
Trimethaphan
Trimethaphan may increase the hypotensive activities of Eprosartan.
Trimethoprim
Trimethoprim may increase the hyperkalemic activities of Eprosartan.
UNOPROSTONE
Eprosartan may increase the hypotensive activities of Unoprostone.
Urapidil
Urapidil may increase the hypotensive activities of Eprosartan.
Valdecoxib
The risk or severity of adverse effects can be increased when Eprosartan is combined with Valdecoxib.
Valsartan
Valsartan may increase the hypotensive activities of Eprosartan.
Vardenafil
Vardenafil may increase the antihypertensive activities of Eprosartan.
Verapamil
The risk or severity of adverse effects can be increased when Verapamil is combined with Eprosartan.
Vincamine
Eprosartan may increase the hypotensive activities of Vincamine.
Vinpocetine
Eprosartan may increase the hypotensive activities of Vinpocetine.
Xylometazoline
Eprosartan may increase the hypotensive activities of Xylometazoline.
Yohimbine
Yohimbine may decrease the antihypertensive activities of Eprosartan.
Zileuton
The risk or severity of adverse effects can be increased when Eprosartan is combined with Zileuton.
Zofenopril
The risk or severity of adverse effects can be increased when Eprosartan is combined with Zofenopril.
Zomepirac
The risk or severity of adverse effects can be increased when Eprosartan is combined with Zomepirac.
